ArticleThe Journal of biological chemistry2015

A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer disease.

Yukiko Hori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.